A new human liver organoid platform could help predict which drugs trigger dangerous immune reactions in susceptible patients ...

Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...

A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...

Researchers at Cincinnati Children’s Hospital Medical Center, in collaboration with Roche, have developed a next-generation ...

Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...

The global human liver model market was valued at USD 1.19 billion in 2023 and is projected to expand at a robust CAGR of 13.8% from 2024 to 2030, culminating in a market size of USD 3.19 billion by ...

A new study from Karolinska Institutet, published in the scientific journal The BMJ, shows how a simple blood analysis can ...

Liver cancer is one of the world's deadliest malignancies, ranking as the third leading cause of cancer-related death.

Hyper-progression recurrence (HPR) after surgery for hepatocellular carcinoma (HCC) is a particularly aggressive relapse ...

Once almost exclusively seen in older adults, fatty liver disease, which can be fatal if untreated, is now one of the world’s ...

Once almost exclusively seen in older adults, fatty liver disease, which can be fatal if untreated, is now one of the world’s fastest-growing diseases. And it’s increasingly occurring in young people ...